Aim: To analyse the clinical profile of otomycosis. Materials and method: The data of this prospective study was collected from patients attending ENT Outpatient Department at tertiary health care centre over a period of two years from JUNE 2021 to October 2022. The study population included patients attending the ENT OPD who gave history of discharge, pain, pruritis and reduced hearing. Over a period of two years, 50 patients were studied. All swabs taken were subjected to microscopic examination by 10% KOH and those positive for fungal elements were inoculated over saborauds dextrose agar. No transport media was used as swabs were immediately inoculated over Saborauds dextrose agar media for 48-72 hours at 37 degree C. The growth of the fungus was studied using gross morphology. Fungus was removed from patients ears once a week for three to four weeks via aural toileting, which included dry mopping, suction clearance, aural syringing, and forceps. The eardrops clotrimazole (4 drops 8 times a day for 4 weeks) were used regardless of the results of the culture.